Boniva - Ibandronate - Dosage - Side Effects - Drug Interactions
Boniva (ibandronate) drug information, dosage, side effects, drug interactions, and warnings. Boniva, generic drug name ibandronate sodium, is a bisphosphonate medicine used to prevent and treat osteoporosis. In Europe, the drug is known as Bonviva. Boniva (ibandronate) is also used to treat other conditions which lead to risk of bone loss.
The Facts of Boniva (Ibandronate Sodium)
Boniva (ibandronate sodium) is used to treat or prevent osteoporosis in women after menopause. Boniva may increase bone mass by slowing loss of bone in most women who take it, even though they won’t be able to see or feel a difference. For Boniva to treat or prevent osteoporosis, you have to take it as prescribed.
Boniva (ibandronate sodium) is used to treat or prevent osteoporosis in women after menopause. Boniva may increase bone mass by slowing loss of bone in most women who take it, even though they won’t be able to see or feel a difference. For Boniva to treat or prevent osteoporosis, you have to take it as prescribed.
Drug Monograph: Boniva / Ibandronate
Ibandronate is a potent, third-generation bisphosphonate. In March 2005, the FDA approved a once monthly formulation of ibandronate (Boniva 150 mg) tablets. In January 2006, the FDA approved an injectable formulation of ibandronate for the treatment of osteoporosis in postmenopausal women. Ibandronate is the first injectable bisphosphonate approved for the treatment of osteoporosis.
Ibandronate is a potent, third-generation bisphosphonate. In March 2005, the FDA approved a once monthly formulation of ibandronate (Boniva 150 mg) tablets. In January 2006, the FDA approved an injectable formulation of ibandronate for the treatment of osteoporosis in postmenopausal women. Ibandronate is the first injectable bisphosphonate approved for the treatment of osteoporosis.
Patient Education: Boniva / Ibandronate Tablets
Patient education for Boniva / ibandronate tablets.
Patient education for Boniva / ibandronate tablets.
Osteoporosis Screening Quiz
Osteoporosis is a condition which is characterized by loss of the normal density of bone, resulting in brittle bones. Brittle bones are subject to fracture. The disease process can be silent (without symptoms) for decades. Do you have symptoms or risk factors for osteoporosis?
Osteoporosis is a condition which is characterized by loss of the normal density of bone, resulting in brittle bones. Brittle bones are subject to fracture. The disease process can be silent (without symptoms) for decades. Do you have symptoms or risk factors for osteoporosis?
Osteoporosis Risk Factor Quiz
The more risk factors you have for a specific disease, the more likely it is you will develop that disease. Do you have any of the risk factors associated with osteoporosis?
The more risk factors you have for a specific disease, the more likely it is you will develop that disease. Do you have any of the risk factors associated with osteoporosis?
What You Need to Know About Steroid Drug-Induced Osteoporosis
Glucocorticoid-induced osteoporosis is both preventable and treatable. Glucocorticoids (steroids) are the most common cause of drug-induced osteoporosis.
Glucocorticoid-induced osteoporosis is both preventable and treatable. Glucocorticoids (steroids) are the most common cause of drug-induced osteoporosis.
Boniva (Ibandronate Sodium)
Boniva is indicated for the treatment and prevention of osteoporosis in postmenopausal women. In March 2005, Boniva received approval in a new formulation, as a once-monthly oral tablet, with a recommended dosage of 150 mg on the same date each month. This approval made Boniva the first ever once-monthly oral treatment for any chronic disease, from CenterWatch.
Boniva is indicated for the treatment and prevention of osteoporosis in postmenopausal women. In March 2005, Boniva received approval in a new formulation, as a once-monthly oral tablet, with a recommended dosage of 150 mg on the same date each month. This approval made Boniva the first ever once-monthly oral treatment for any chronic disease, from CenterWatch.